M2-Polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pn0 pancreatic cancer

Pancreas

Volumn 42, Issue 1, 2013, Pages 155-159

  Kurahara, Hiroshi ^a   Takao, Sonshin ^b   Maemura, Kosei ^a   Mataki, Yuko ^a   Kuwahata, Taisaku ^a,b   Maeda, Koki ^a,b   Sakoda, Masahiko ^a   Iino, Satoshi ^a   Ishigami, Sumiya ^a   Ueno, Shinichi ^a   Shinchi, Hiroyuki ^a   Natsugoe, Shoji ^a  

^a Department of Cardiovascular   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

isolated tumor cell; lymph node metastasis; lymphangiogenesis; pancreatic cancer; tumor associated macrophage; VEGF C

Indexed keywords

CD163 ANTIGEN; CYTOKERATIN AE1; CYTOKERATIN AE3; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY D2-40; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL INFILTRATION; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL DENSITY; LYMPHANGIOGENESIS; LYMPHATIC PARAMETERS; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGIONAL LYMPH NODE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KI-67 ANTIGEN; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RECEPTORS, CELL SURFACE; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84872075318     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318254f2d1     Document Type: Article

References (29)

1. Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10-15.
2. Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010;7:163-172.
3. Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. 2008;247:456-462.
4. Kanda M, Fujii T, Nagai S, et al. Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas. 2011;40:951-955.
5. Demeure MJ, Doffek KM, Komorowski RA, et al. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reactionYbased assay. Cancer. 1998;83:1328-1334.
6. Kurahara H, Takao S, Maemura K, et al. Impact of lymph node micrometastasis in patients with pancreatic head cancer. World J Surg. 2007;31:483-490; discussion 491-492.
7. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423-1425.
8. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-198.
9. Ma?kinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199-205.
10. Gombos Z, Xu X, Chu CS, et al. Peritumoral lymphatic vessel density and vascular endothelial growth factor c expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res. 2005;11:8364-8371.
11. Hinojar-Gutiérrez A, Fernández-Contreras ME, González-González R, et al. Intratumoral lymphatic vessel and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 N0 laryngopharyngeal squamous cell carcinoma. Ann Surg Oncol. 2007;14:248-257.
12. Cohen-Kaplan V, Naroditsky I, Zetser A, et al. Heparanase induces VEGF-C and facilitates tumor lymphangiogenesis. Int J Cancer. 2008;123:2566-2573.
13. Kurahara H, Takao S, Maemura K, et al. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res. 2004;10:8413-8420.
14. Kurahara H, Takao S, Shinchi H, et al. Significance of lymphangiogenesis in primary tumor and draining lymph nodes during lymphatic metastasis of pancreatic head cancer. J Surg Oncol. 2010;102:809-815.
15. Schoppmann SF, Birner P, Sto?ckl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002;161:947-956.
16. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605-612.
17. Mantovani A, Romero P, Palucka AK, et al. Tumor immunity: effector response to tumor and role of the microenvironment. Lancet. 2008;371:771-783.
18. Schoppmann SF, Fenzl A, Nagy K, et al. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery. 2006;139:839-846.
19. Gallego E, Vicioso L, Á lvarez M, et al. Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas. Virchows Arch. 2011;458:621-630.
20. Qian CN, Berghuis B, Tsarfaty G, et al. Preparing the ''soil'': the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res. 2006;66:10365-10376.
21. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol. 2007;170:774-786.
22. Mumprecht V, Honer M, Vigl B, et al. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immune-positron emission tomography. Cancer Res. 2010;70:8842-8851.
23. Sobin LH, Wittekind CH. International Union Against Cancer. TNM Classification of Malignant Tumours. 6th ed. New York: Wiley-Liss; 2002.
24. Birner P, Schindl M, Obermair A, et al. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer. 2001;95:29-33.
25. Iwata C, Kano MR, Komuro A, et al. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res. 2007;67:10181-10189.
26. Kubota Y, Takubo K, Shimizu T, et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med. 2009;206:1089-1102.
27. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer. 2003;98:413-423.
28. Van den Eynden GG, Vandenberghe MK, van Dam PJ, et al. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res. 2007;13(pt 1):5391-5397.
29. Hirakawa S, Brown LF, Kodama S, et al. VEGF-CYinduced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood. 2007;109:1010-1017.